Seeking Alpha

Dr. Paul Nunzio DeSantis, Pharm.D

 
View Dr. Paul Nunzio DeSantis, Pharm.D's StockTalks BY TICKER:
  • Dr. Paul Nunzio DeSantis, Pharm.D
    GBIM: Technical Move Confirms Breakout Today $GBIM http://seekingalpha.com/p/23uwn
    Dec 9, 4:56 PM
    Reply
      • Dr. Paul Nunzio DeSantis, Pharm.D
        CO-1686 Data Confirmed Efficacy, Take Advantage Of Weakness In Clovis Oncology Shares Ahead Of... $CLVS http://seekingalpha.com/a/1lrrt
        Nov 19, 11:41 AM
        Reply
          • Dr. Paul Nunzio DeSantis, Pharm.D
            Achillion Pharmaceuticals: Still Bullish, But Taking Profits $ACHN http://seekingalpha.com/a/1lcdn
            Nov 12, 5:06 PM
            Reply
              • Dr. Paul Nunzio DeSantis, Pharm.D
                INCY: GREAT QUARTER, STILL SEE LONG TERM UPSIDE TO $93, BUT BOOKING SOME PROFITS HERE $INCY http://seekingalpha.com/p/216mj
                Oct 30, 12:27 PM
                Reply
                  • Dr. Paul Nunzio DeSantis, Pharm.D
                    Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction... $INSIF http://seekingalpha.com/a/1jsgl
                    Oct 28, 4:16 AM
                    Reply
                      • Dr. Paul Nunzio DeSantis, Pharm.D
                        Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder $ACHN http://seekingalpha.com/a/1ido9
                        Oct 2, 2:48 PM
                        Reply
                          • Dr. Paul Nunzio DeSantis, Pharm.D
                            Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93,... $INCY http://seekingalpha.com/a/1hbjh
                            Sep 11, 10:49 AM
                            Reply
                              • Dr. Paul Nunzio DeSantis, Pharm.D
                                PSivida Corp (PSDV): Imminent New Drug Approval, Steady News Flow, & Tethadur Partnership Raising... $PSDV http://seekingalpha.com/a/1fr4n
                                Aug 12, 12:46 PM
                                Reply
                                  • Dr. Paul Nunzio DeSantis, Pharm.D
                                    $4.1B Sovaldi Sales Est. Wrong, Heres Why, We Think $GILD http://seekingalpha.com/p/1uc0h
                                    Jul 24, 6:09 PM
                                    Reply
                                      • Dr. Paul Nunzio DeSantis, Pharm.D
                                        Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year $GILD http://seekingalpha.com/a/1e3yx
                                        Jul 24, 11:25 AM
                                        Reply
                                          • Dr. Paul Nunzio DeSantis, Pharm.D
                                            Gilead Sciences Should Report $4B In Sovaldi Sales In Q2'14 $GILD http://seekingalpha.com/a/1dyjn
                                            Jul 22, 5:03 PM
                                            Reply
                                              • Dr. Paul Nunzio DeSantis, Pharm.D
                                                Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A) $MGNX http://seekingalpha.com/a/1dy4d
                                                Jul 22, 3:20 PM
                                                Reply
                                                  • Dr. Paul Nunzio DeSantis, Pharm.D
                                                    Sovaldi And GILD 2Q $4.1B Possible, $3.5B Minimum $GILD http://seekingalpha.com/p/1tyo7
                                                    Jul 18, 11:20 AM
                                                    Reply (5)
                                                  • View all 5 replies
                                                    • combatcorpsmanVN: If GILD's quarterly earnings are anywhere near $4B -- that number will be rocket fuel for the shares. October will be the acid test imo.
                                                      Jul 22, 3:35 PM
                                                    • combatcorpsmanVN: I have my full allotment but $4B -- I'll be back accumulating shares. I'm bullish on GILD but I have to see that number to be convinced.
                                                      Jul 22, 3:37 PM
                                                      • Dr. Paul Nunzio DeSantis, Pharm.D
                                                        Shire (SHPG) Bid Came In As Expected $ABBV, $SHPG http://seekingalpha.com/p/1tnl1
                                                        Jul 14, 4:38 AM
                                                        Reply (2)
                                                        • combatcorpsmanVN: Well, Ireland is 'Green' for more reasons than rain -- 12.5% corporate tax rate! No wonder ABBV believes the 'grass is greener' there.
                                                          Jul 22, 3:39 PM
                                                        • Dr. Paul Nunzio DeSantis, Pharm.D: Right?! I'd be looking for a lucky charm if I was a US Pharma company too
                                                          Jul 22, 3:41 PM
                                                          • Dr. Paul Nunzio DeSantis, Pharm.D
                                                            GREAT POINT PARTNERS LLC Files 13-G On Oncogenex (OGXI) $OGXI http://seekingalpha.com/p/1tarx
                                                            Jul 7, 5:09 PM
                                                            Reply (1)
                                                            • tedy77: sounds like good
                                                              Jul 9, 2:22 PM
                                                              • Dr. Paul Nunzio DeSantis, Pharm.D
                                                                Consider Shire Pharmaceuticals Now; +20% Upside Left In Takeover Bid By Abbvie $SHPG http://seekingalpha.com/a/1d533
                                                                Jun 30, 10:38 AM
                                                                Reply
                                                                  • Dr. Paul Nunzio DeSantis, Pharm.D
                                                                    Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens $GILD http://seekingalpha.com/a/1chmb
                                                                    Jun 10, 5:47 PM
                                                                    Reply
                                                                      • Dr. Paul Nunzio DeSantis, Pharm.D
                                                                        Gilead Going To Buy Macrogenics (MGNX) Over Next 2 Years http://seekingalpha.com/p/1qehf
                                                                        May 13, 6:19 PM
                                                                        Reply
                                                                          • Dr. Paul Nunzio DeSantis, Pharm.D
                                                                            Tweet Of The Week On Gilead: Carl Icahn Entering Gilead? $GILD http://seekingalpha.com/p/1pn1n
                                                                            Apr 29, 11:15 PM
                                                                            Reply
                                                                              • Dr. Paul Nunzio DeSantis, Pharm.D
                                                                                OncoGenex: Phase 3 Trial In First Line Metastatic Prostate Cancer Fails, Now What? $OGXI http://seekingalpha.com/a/1aiqn
                                                                                Apr 28, 5:17 PM
                                                                                Reply